MahaA.ElkordyMD

PubMed

• 11 citations
  Results of a phase II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based clinic?
  William R. Berry, Maha Elkordy, Mark A. O'Rourke, Myrna Khan, Lina Asmar> ;Cancer Investigation. 2007 Feb 1
• 1 citations
  Phase II Trial of a Novel Paclitaxel Schedule As Single-Agent, First-Line Therapy for HER-2/neu–Negative Metastatic Breast Cancer: A Community-Based Study
  David M. Loesch, Nicholas J. Robert, Stephen E. Jones, Maha Elkordy, Des Ilegbodu, Lina Asmar> ;Journal of Oncology Practice. 2006 Nov 1
• 54 citations
  Prognostic and Predictive Factors for Patients With Metastatic Breast Cancer Undergoing Aggressive Induction Therapy Followed by High-Dose Chemotherapy With Autologous...
  David A. Rizzieri, James J. Vredenburgh, Robert Henry Jones, Maureen Ross, Elizabeth J. Shpall, A. Hussein, Gloria Broadwater, Donald A. Berry, William P. Petros, Coll...> ;Journal of Clinical Oncology. 1999 Oct 1
• 6 citations
  The addition of paclitaxel to continuous infusion 5-fluorouracil is an active regimen for metastatic breast cancer.
  James J. Vredenburgh, Fishman R, David Coniglio, Matters L, M. Elkordy, Merrick I. Ross, A. Hussein, P. Rubin, Colleen J. Gilbert, William P. Petros, William P. Peters> ;American Journal of Clinical Oncology. 1998 Dec 1
• 29 citations
  A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with ...
  James J. Vredenburgh, A. Hussein, David Fisher, Maureane Hoffman, M. Elkordy, P. Rubin, Colleen J. Gilbert, James A. Kaye, Kevin Dykstra, John Loewy, William P. Peters> ;Biology of Blood and Marrow Transplantation. 1998 Nov 1
• 21 citations
  Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-o...
  David Fisher, James J. Vredenburgh, William P. Petros, A. Hussein, Donald A. Berry, M. Elkordy, P. Rubin, Colleen J. Gilbert, William P. Peters> ;Bone Marrow Transplantation. 1998 Jan 1
• 14 citations
  A phase I trial of recombinant human interleukin-1β (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation
  M. Elkordy, M. Crump, James J. Vredenburgh, William P. Petros, A. Hussein, P. Rubin, Maureen Ross, Colleen J. Gilbert, C. Modlin, David Coniglio, Joshua D. Rabinowitz,...> ;Bone Marrow Transplantation. 1997 Feb 2
• 8 citations
  Ocular toxicity following high dose chemotherapy and autologous transplant.
  P. Rubin, Christine M. Hulette, Joseph A. Khawly, M. Elkordy, A. Hussein, James J. Vredenburgh, Glenn J. Jaffe, William P. Peters> ;Bone Marrow Transplantation. 1996 Jul 1
• 24 citations
  Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.
  David Fisher, G B Sherrill, A. Hussein, P. Rubin, James J. Vredenburgh, M. Elkordy, Maureen Ross, William P. Petros, William P. Peters> ;Bone Marrow Transplantation. 1996 Jul 1
• 22 citations
  A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed periphera...
  A. Hussein, William P. Petros, Maureen Ross, James J. Vredenburgh, Mary Lou Affronti, Roy B. Jones, Elizabeth J. Shpall, P. Rubin, M. Elkordy, Colleen J. Gilbert, Caro...> ;Cancer Chemotherapy and Pharmacology. 1996 Jan 1
• 3 citations
  The use of growth factors with antibiotics in the setting of neutropenic fever
  A. Hussein, M. Elkordy, William P. Peters> ;The American Journal of Medicine. 1996 Jan 1
• 49 citations
  Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer.
  Rodney J. Folz, M. Elkordy> ;Chest. 1999 Mar 1
• Join now to see all